| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95cb36c769b6d7b94e5219aaddb1155b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adfafd5c0a828e7d0c7010d930e0a6d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20ebd1cb3cabc086c5a6bb15f3c0c0b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ddb3f99989652bb8ed44fcf73880fc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fe337c9f4fad89d9f10c5a30e9697d6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
| filingDate |
2007-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_291f3c7109018f1b49e49ee9c561c5f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c3c8c1cb7b42ebfda5e4b1458431e42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a8d2389fdefe9c92a7fb88fb9b1df3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6d0b8db7b9bee1a1e8326bb4aa8c4ba |
| publicationDate |
2008-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008055022-A2 |
| titleOfInvention |
Carbamate compounds for use in treating depression |
| abstract |
The present invention is a method for the treatment of depression comprising administering to a subject in need thereof a therapeutically effective amount of one or more carbamate compounds of Formula 1 and/or Formula 2 as herein defined and shown below for the treatment of depression. Formula 1 Formula 2 The present invention is directed to a method for the treatment of depression, which includes mono-therapy and alternatively, co-therapy with at least one additional antidepressant. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609849-B1 |
| priorityDate |
2006-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |